Braftovi

Braftovi Warnings and Precautions

• Treatment with Braftovi may increase the risk of developing new skin cancers and other cancers. Your doctor will check your skin before, during, and after treatment. Report any new skin growths, sores, or changes in existing moles immediately.
• This medicinal product works only in cancers with a confirmed BRAF V600E or V600K mutation. Your doctor will perform an approved genetic test before starting treatment to ensure this medicine is suitable and effective for your condition.
• Braftovi, especially with binimetinib, may reduce the heart's pumping ability. Your doctor will monitor your heart before and during treatment. Report shortness of breath, swollen ankles, tiredness, or an irregular heartbeat immediately.
• Encorafenib may affect liver function. Regular blood tests will be performed before and during treatment. Tell your doctor immediately if you notice yellowing of the skin or eyes, dark urine, severe tiredness, or abdominal pain.
• Therapy with Encorafenib may cause serious bleeding, including in the stomach, intestines, or brain. Seek medical attention immediately if you notice unusual bruising, blood in stools, urine, or vomit, coughing up blood, or severe headaches.
• This medicine may cause eye conditions such as uveitis, iritis, or iridocyclitis. Regular eye examinations are recommended. Contact your doctor immediately if you experience blurred vision, eye pain, redness, or any changes in vision.
• Braftovi may affect your heart rhythm by prolonging the QT interval. Your doctor may monitor your ECG and blood electrolytes during treatment, especially if you take other medicines that can affect heart rhythm.
• Encorafenib may harm an unborn baby. Use effective non-hormonal contraception during treatment and as advised after the last dose. Avoid breastfeeding during treatment and for two weeks afterward. Braftovi may also affect male fertility.
• This drug can interact with many medicines, herbal supplements, and certain foods. Always inform your doctor and pharmacist about all prescription medicines, over-the-counter products, vitamins, and supplements before starting treatment.
• Braftovi is often given with binimetinib, cetuximab, or chemotherapy. The safety warnings, precautions, monitoring, and possible side effects of these medicines also apply, so follow your healthcare provider's instructions carefully.

How to Access Braftovi in India: A 6-Step Process

• Step 1 – Search & request your medicine: The patient or treating doctor submits a request with basic details to initiate the access process.
• Step 2 – Verification & eligibility review: The team verifies availability and reviews eligibility against regulatory and clinical requirements — including confirmation of the BRAF V600E mutation report — to ensure a compliant pathway.
• Step 3 – Receive quote & delivery timeline: A transparent quotation is shared, covering medicine cost, logistics, and a clear delivery timeline.
• Step 4 – Regulatory approval process: Assistance is provided to secure the approvals and documentation required for legal cross-border access.
• Step 5 – Compliant import & handling: The medicine is sourced and transported under strict GDP-compliant, controlled-temperature conditions to maintain product integrity.
• Step 6 – Secure delivery: The medicine is delivered to the patient or treating hospital, with updates provided at each stage.

Access This Process Easily via Our App

You can manage the entire process seamlessly through the Named Patient Program App, available on both the Play Store and App Store.

• Track your medicine request in real-time
• Upload documents and approvals
• View quotations and timelines
• Get status updates at every step

You can also access detailed information by clicking Login in the website header. On mobile, open the hamburger menu (☰) and tap Login from the dropdown to get started.

Documentation & Availability

What documents are required to import BRAFTOVI to India?

• A valid prescription from a qualified doctor
• The patient's diagnostic reports, including the molecular/genomic test report confirming a BRAF V600E (or V600K) mutation
• Patient ID proof (issued by the Government of India)
• 
  

How is the order confirmed?

Sourcing & Delivery of Braftovi

NamedPatientProgram.com (NPP) can source Braftovi from reliable global manufacturers and qualified pharmaceutical supply channels and facilitate supply to patients, doctors, and hospitals under applicable legal provisions. As an oral solid dosage form, Braftovi is shipped under GDP-compliant controlled room-temperature conditions with full batch traceability and tamper-evident, sealed original packaging.

All prescriptions are dispensed and checked by registered pharmacists and dispatched from New Delhi, India, after legal requirements are fulfilled.

For Braftovi cost in India and availability, contact NPP via WhatsApp at +91 98104 69557 | Toll-Free: 1800-1200-365 or email info@namedpatientprogram.com.

Availability of Braftovi® Across Major Cities in India

Patients across India can access Braftovi® through regulated import pathways, with delivery arranged to the treating hospital or patient based on a valid oncologist's prescription.

Mumbai: A major oncology hub with institutions like Tata Memorial, Mumbai, sees high demand for biomarker-driven therapies like Braftovi®. Access is often coordinated for patients undergoing specialized colorectal, melanoma and lung cancer care.

Bangalore: With a growing network of multispecialty hospitals and molecular diagnostic laboratories, Bangalore supports access to global targeted therapies through structured import pathways guided by treating specialists.

Delhi: As part of the Delhi NCR region, the city has a strong concentration of cancer centers and medical oncologists, making it a key location for accessing advanced imported therapies.

Gurgaon: Home to leading hospitals like Medanta, Gurgaon plays an important role in facilitating access to innovative cancer treatments through coordinated care pathways.

Noida: With proximity to Delhi and access to top hospitals, Noida patients benefit from streamlined logistics and specialist-driven treatment planning.

Hyderabad: Hyderabad's advanced healthcare infrastructure and precision oncology expertise support patients seeking access to internationally approved cancer therapies.

Chennai: Known for its established medical ecosystem, Chennai attracts patients from across India for complex cancer treatments and specialized drug access.

Kolkata: A key eastern healthcare hub, Kolkata offers access to advanced oncology care through leading hospitals and treatment centers.

Ahmedabad: Ahmedabad's expanding healthcare sector and oncology facilities support patients requiring advanced and imported cancer therapies.

Pune: With reputed hospitals and a growing cancer care infrastructure, Pune is an emerging center for access to specialized oncology treatments.

Chandigarh: Serving North India, Chandigarh provides access to advanced medical care through reputed institutions and specialist-led treatment planning.

Jaipur: Jaipur's improving healthcare network enables patients to explore access to innovative cancer therapies through structured import processes.

Lucknow: As a major city in North India, Lucknow supports access to advanced oncology treatments through both public and private healthcare institutions.

Indore: Indore is emerging as a regional healthcare hub, offering access to specialized cancer care and modern treatment pathways.

Bhopal: Patients in Bhopal can access advanced cancer treatments through the growing healthcare infrastructure and referral networks.

Nagpur: Nagpur serves as a central hub for patients across Vidarbha, with increasing access to oncology care and specialized therapies.

Surat: Surat's developing healthcare ecosystem supports patients seeking access to global oncology treatments through coordinated care.

Patna: As a major city in Eastern India, Patna provides growing access to cancer treatment through expanding hospital networks.

Coimbatore: Coimbatore is known for quality healthcare services, offering access to advanced oncology treatments in South India.

Kochi: With modern hospitals and specialist care, Kochi enables patients to explore access to internationally approved cancer therapies.

Note: Access timelines may vary depending on documentation, regulatory approvals, and sourcing logistics.

Access/Buy Braftovi® at Leading Hospitals in India

Braftovi® is typically used in advanced melanoma, colorectal and lung cancer settings where molecular testing guides treatment, and can be accessed at leading hospitals across India, where specialists guide treatment decisions and coordinate patient-specific access pathways.

Major Hospitals Covered:

• Tata Memorial Centre: One of India's premier cancer institutes, Tata Memorial plays a key role in managing BRAF-mutant colorectal, melanoma and lung cancer cases and guiding patients toward advanced therapies like Braftovi®.
• AIIMS: As a leading government medical institution, AIIMS provides comprehensive cancer care and supports patients requiring access to specialized and emerging treatments.
• Apollo Hospitals: With a nationwide presence, Apollo Hospitals offers advanced oncology services and facilitates access to global treatment options through its extensive medical network.
• Fortis Healthcare: Fortis hospitals are equipped with modern cancer care facilities and multidisciplinary teams that manage complex treatment pathways for patients.
• Max Healthcare: Max Healthcare is known for its strong medical oncology departments, providing access to innovative targeted therapies under expert clinical supervision.
• Manipal Hospitals: Manipal Hospitals supports advanced cancer care through experienced specialists and structured treatment planning across multiple cities.
• Kokilaben Dhirubhai Ambani Hospital: A leading private hospital in Mumbai, Kokilaben Hospital offers cutting-edge oncology care and access to advanced global therapies.
• Medanta – The Medicity: Medanta is a renowned super-specialty hospital where complex cancer cases are managed with advanced treatment protocols and global access support.
• BLK-Max Super Speciality Hospital: BLK-Max provides comprehensive oncology services and supports patients seeking access to specialized treatment options.
• Rajiv Gandhi Cancer Institute: A dedicated cancer care center, RGCI focuses on advanced oncology treatments and supports patients through complex treatment journeys.
• HCG Cancer Centre: HCG is a specialized cancer hospital network known for its focus on precision oncology and advanced treatment modalities.
• Narayana Health: Narayana Health combines affordability with advanced medical care, offering oncology services across multiple locations in India.
• Amrita Hospital: Amrita Hospital provides high-quality cancer care with a focus on patient-centric treatment and access to modern therapies.
• Yashoda Hospitals: Yashoda Hospitals are known for their strong oncology departments and advanced treatment infrastructure in South India.
• Aster Hospitals: Aster Hospitals offer integrated cancer care services and support access to innovative therapies through coordinated treatment planning.
• Sir Ganga Ram Hospital: A well-established hospital in Delhi, Sir Ganga Ram provides multidisciplinary cancer care supported by experienced specialists.
• Jaslok Hospital: Jaslok Hospital is known for its specialized medical services and advanced oncology treatment capabilities.
• Ruby Hall Clinic: Ruby Hall Clinic offers comprehensive cancer care and supports patients requiring advanced and imported therapies.
• CARE Hospitals: CARE Hospitals provide modern oncology treatment facilities and multidisciplinary care across multiple cities.
• Global Hospitals: Global Hospitals are equipped with advanced medical technologies and oncology expertise to manage complex cancer cases.

Note: Braftovi® is not stocked for direct purchase but is arranged through compliant import processes and delivered to the patient or hospital for patient-specific treatment.